Larry Gerrans is the inventor of breakthrough medical technologies to improve the treatment of lung cancer and other major diseases worldwide.
Lung cancer is the leading cause of cancer death and the second-leading cause of all deaths in the U.S.
The U.S. healthcare system is about to be deluged with diagnoses of early-stage Lung Cancers, and therefore we need to develop appropriate therapies for peripheral tumors, where the majority of lung cancers begin.
But lung cancer authority, Larry Gerrans, warns that U.S. healthcare system resources are “grossly inadequate”to treat peripheral tumors. This shortage is due to Medicare coverage of Lung Cancer screening for at-risk beneficiaries going into effect in 2015.
In addition to writing over 100 patents, as the Founder, President & CEO of Sanovas, Inc., Larry Gerrans has been leading an elite group of innovators developing groundbreaking interventional technologies to treat the diseases of the Lung and to cure Lung Cancer.
The Sanovas platform features highly sophisticated 3D imaging and physiologic intelligence systems that operate within new sensory guided interventional technologies to provide the local delivery of drug and immune therapies to significantly improve cancer treatment.
Book Larry Gerrans, Medical Technologies Expert to discuss...
- Lung Cancer Incidence / Precedence
- Traditional treatments for Lung Cancer
- Lung Cancer Screening
- New Therapies for Lung Cancer
Larry Gerrans Guest Expert Interview Credentials
- Founder, President & CEO of Sanovas, Inc.
- Author of over 100 patents
Guest Expert Availability
By telephone from San Rafael, CA PST
In Person in San Francisco
Guest Expert Interview Booking Contact
Ronald Trahan
Email Ronald at rtrahan@ronaldtrahan.com
(508) 359-4005
Guest Expert Web Site
-------------------------
See more Featured Radio Talk Show Guest Experts here.
Would you like to be listed as a Featured Talk Show Guest Expert?
Our web site and email promotions can showcase your expertise worldwide!
Please see our easy Guest Expert Advertising options here!